• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY IRELAND - 3015516266 BI-MENTUM ALTRX; HIP IMPLANT - ACETABULAR LINER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY IRELAND - 3015516266 BI-MENTUM ALTRX; HIP IMPLANT - ACETABULAR LINER Back to Search Results
Catalog Number 122122043
Medical Device Problem Code Device Dislodged or Dislocated (2923)
Health Effect - Clinical Codes Pain (1994); Joint Dislocation (2374)
Date of Event 04/08/2026
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that patient presented in office for follow up post dislocation and pain.X-rays revealed eccentricity of the implant post hip relocation and the surgeon suspected a head-liner disassociation during the attempted relocation.Revision total hip arthroplasty was scheduled, and intraoperatively, the poly liner was found disassociated with loosening at the non-cemented interface.Both the liner and a well-fixed femoral head were removed due to potential damage, along with the metal dm liner.New components were implanted without delay or patient harm, and hip range of motion was stable post-procedure.It is believed the poly liner disassociation occurred during the attempted relocation, as previous imaging showed all components well fixed and functioning.Doi: (b)(6) 2025.Dor: (b)(6) 2026.Affected side: left hip.
 
Additional Manufacturer Narrative
Product complaint: (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803 (and/or part 4, as applicable).This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes, or its employees that the report constitutes an admission that the product, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Additional Manufacturer Narrative
Product complaint #(b)(4).Investigation summary: no device associated with this report was received for examination.The product investigation found no evidence suspecting an error in the manufacturing or material that would be a contributing factor in the reported allegation(s).A records evaluation (mre) was not perform.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.Additional complaint information monitoring for potential safety signals will be conducted through complaint trending as part of the post-market surveillance.If additional information is made available, the investigation will be updated as applicable.Device history lot: the product investigation found no evidence suspecting an error in the manufacturing or material that would be a contributing factor in the reported allegation(s).A manufacturing records evaluation (mre) was not performed.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes joint reconstruction, or its employees that the report constitutes an admission that the product, depuy synthes joint reconstruction, or its employees caused or contributed to the potential event described in this report.H11 additional narrative: added: b5, d10 concomitant.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Event or Problem Description
Additional information received: a.Was/were there any adverse consequence/s that affected the patient because of the reported event? - other than some discomfort post attempted relocation, no adverse consequences were noted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BI-MENTUM ALTRX
Common Device Name
HIP IMPLANT - ACETABULAR LINER
Manufacturer (Section D)
DEPUY IRELAND - 3015516266
loughbeg ringaskiddy co.
cork
EI 
Manufacturer (Section G)
LEEDS MFG & MATERIAL WAREHOUSE
st anthonys road
leeds LS11 8DT
UK   LS11 8DT
Manufacturer Contact
elba bello
700 orthpaedic dr.
warsaw, IN 46581
9083863534
MDR Report Key24971632
Report Number1818910-2026-07513
Device Sequence Number18749074
Product Code LZO
UDI-Device Identifier10603295525363
UDI-Public(01)10603295525363(17)300228(10)4730440
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K203532
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Device Explanted Year2026
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number122122043
Device Lot Number4730440
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 04/08/2026
Supplement Date Received by Manufacturer04/24/2026
04/29/2026
Initial Report FDA Received Date04/23/2026
Supplement Report FDA Received Date04/29/2026
04/30/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/10/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ARTICULEZE HD CER 22.225 +4.; PINNACLE DM LINER 50_43.
Outcome Attributed to Adverse Event Required Intervention;
Patient Age74 YR
Patient SexMale
Patient Weight53 KG
-
-